2017 Annual Report
This report describes achievements and activities from July 1, 2016, through June 30, 2017.
In 2017, BTEC marks 10 years of progress creating a brighter future for North Carolina. See how the past year’s accomplishments in academic and professional development programs, along with contract services, contribute to the success of the state’s citizens, businesses, and economy.
BTEC offers programs at the undergraduate, post-baccalaureate, and graduate levels for students with a variety of backgrounds including engineering, the life sciences, and chemistry. Undergraduates can earn a minor or certificate in biomanufacturing, and non-degree students can obtain a post-baccalaureate certificate. At the graduate level, BTEC offers two Professional Science Master’s degrees, a graduate minor, and two graduate certificates.
Enrollment remains strong
Program completion is on track
Stellar employment rates continue
BTEC boasted employment/placement rates of 95% for undergraduates and 98% for graduate students in 2016–17. Graduates of BTEC’s master’s program have been hired by 25 different biomanufacturing/biotechnology companies. (Percentages indicate employment or acceptance into a graduate program within six months of graduation.)
2017 summer internships
During summer 2017, BTEC sponsored seven undergraduate interns, four of whom were participants in the Research Experience for Undergraduates program. Students conducted research under the supervision of BTEC faculty and staff, learned about various aspects of university research, and presented their work at symposia.
BTEC expands the expertise of biotechnology and biomanufacturing professionals and supports the industry through its professional development programs. The center offers open enrollment short courses and a certi cate program, courses that are customized for organizations, seminars, and other events.
Training participants by job function
BTEC also provided training for the 10th cohort of U.S. Food and Drug Administration personnel. Each year, an average of 15 FDA eld staff complete a series of four courses in this training program, which was developed speci cally for the FDA and has been provided under contract since 2007.
Effective July 1, 2017, Dr. Gary Gilleskie became BTEC's acting director, when Dr. Ruben G. Carbonell took leave from that position to assume the role of chief technology of cer for the new National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL). NIIMBL is the first manufacturing innovation institute sponsored by the U.S. Department of Commerce to advance U.S. leadership in biopharmaceutical manufacturing. BTEC anticipates ongoing involvement with NIIMBL as the new manufacturing innovation institute generates projects and related opportunities.
Since its Contract Services program began in 2009–10, BTEC has completed 137 bioprocess and analytical projects for a variety of local, national and international firms. The past year has been our most productive ever with 28 projects, a 75% increase from the previous year. BTEC’s expertise and equipment in nearly all areas of our facilities are utilized to provide a range of services, such as amino acid analysis of spent media; beta testing of new disposable bioreactors; optimization of puri cation of recombinant proteins; scale-up and production of bacterial cell mass; and testing of growth conditions for expression of fusion proteins. Contract Services clients include start-ups with drug, bio-agriculture, and industrial products, as well as suppliers of bioprocess equipment.
Photos from 2016–17
View the online album of photos from 2016–17.
View or download the printed copy of the BTEC 2017 Annual Report (PDF).